Crowley John J 4
4 · Centessa Pharmaceuticals plc · Filed Jul 2, 2024
Insider Transaction Report
Form 4
Crowley John J
Chief Financial Officer
Transactions
- Award
Share Option (right to buy)
2024-07-01+600,000→ 600,000 totalExercise: $8.80Exp: 2034-07-01→ Ordinary Shares (600,000 underlying)
Footnotes (2)
- [F1]25% of the shares subject to such option shall vest and become exercisable on July 1, 2025 and the remaining 75% of the shares subject to such option shall vest and become exercisable in 36 monthly installments on the first day of each month thereafter.
- [F2]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.